TyG index significantly linked to heart failure with preserved ejection fraction, suggests study
A recent study published in the Frontiers in Endocrinology journal showed that heart failure with preserved ejection fraction (HFpEF) in patients with congenital heart disease (CHD) was shown to be significantly correlated with the triglyceride-glucose (TyG) index. Even with advancements in treatment, heart failure (HF) continues to place a heavy strain on the global healthcare system. Diabetes and a higher risk of metabolic and atherosclerotic cardiovascular diseases are positively correlated with the TyG index. Also, there has been evidence of a beneficial relationship between the prognosis of HF patients and the TyG index. Insulin resistance can be inferred from the triglyceride-glucose index. And so, Li Z and team carried out this study with to look if the TyG index and heart failure with preserved ejection fraction in patients with coronary heart disease (CHD) would be influenced by various metabolic conditions.
A total of 62,794 of the 107,301 CHD patients were included in order to examine the connection between HF and the TyG index. To distinguish between the various forms of heart failure, such as HF with decreased ejection fraction (HFrEF), HF with intermediate-range ejection fraction (HFmrEF), and HFpEF, 8,606 patients who had undergone echocardiography were included. 1896 of them had a diagnosis of HFpEF.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.